Zimmer Biomet Adds CD Diagnostics To List Of 2016 Acquisitions

 
• By Reed Miller

The deal will add musculoskeletal diagnostic tests to Zimmer Biomet's new Signature Solutions consulting and technology program. It is the orthopedics giant's sixth acquisition of 2016.

A week after launching a new comprehensive consulting and technology program to help hospitals manage orthopedic surgery episodes-of-care, Zimmer Biomet Holdings Inc. is adding in vitro diagnostics to the program with an acquisition of CD Diagnostics.

On Aug. 15, Zimmer Biomet announced plans to acquire the Claymont, Del.-based company, which specializes in diagnostics based on biomarkers...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Orthopedics

More from Device Area